Limits of Use: Mounjaro has not been studied in individuals having a historical past of pancreatitis. Mounjaro isn't indicated to be used in patients with type one diabetes mellitus. Tirzepatide is actually a GIP receptor and GLP-one receptor agonist. It's a 39-amino-acid modified peptide